The following is a summary of "Comparison of prognostic scores according to WHO classification in 170 patients with advanced ...

Cogent Biosciences' uncertain competitive edge may compel investors to sit on the sidelines. Read more about the cautious ...

A standard treatment for mastocytosis is difficult to apply to individual patients based on the variable clinical course. A general consensus for using antimediator agents such as antihistamines ...

If you're coping with episodic facial flushing you may be frustrated at how hard it is to get a diagnosis. What is facial flushing related to mastocytosis like and what are some of the conditions ...

In September of 2000, the world's leading experts in MC met to discuss and present data at the "Year 2000 Working Conference on Mastocytosis," held in Vienna, Austria. Table 1 presents a uniform ...

Sudipto Mukherjee, MD, PhD, MPH, of Cleveland Clinic, describes the steps clinicians should take when they encounter clinical abnormalities that may point to systemic mastocytosis. (1:48 ...

Opens in a new tab or window An analysis of registry data concluded that hypersensitivity reactions in patients with mastocytosis are caused by exposure to certain triggers, including low tryptase ...

Blueprint Medicines' AYVAKIT continues to gain traction among key stakeholders. See more on BPMC stock and the factors ...

After hours: September 30 at 7:36 PM EDT Loading Chart for BPMC ...

Systemic mastocytosis (SM) is driven by KIT D816V mutation in approximately 95% of cases. 1 With the emergence of targeted treatments for indolent systemic mastocytosis (ISM) comes an opportunity to ...

After months of unanswered questions, Laura was finally told that her 17-month-old had mastocytosis - a rare condition caused by an excess number of mast cells gathering in the body's tissues.